Dana Rosenberg

910 total citations
6 papers, 72 citations indexed

About

Dana Rosenberg is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Dana Rosenberg has authored 6 papers receiving a total of 72 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Dana Rosenberg's work include Bone health and treatments (3 papers), Bone Metabolism and Diseases (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Dana Rosenberg is often cited by papers focused on Bone health and treatments (3 papers), Bone Metabolism and Diseases (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Dana Rosenberg collaborates with scholars based in Israel. Dana Rosenberg's co-authors include Anat Gafter‐Gvili, Talia Diker‐Cohen, Gloria Tsvetov, Tomer Avni, Daniel Shepshelovich, Nadav Sarid, Erel Joffe, Svetlana Trestman, Yair Herishanu and Elizabeth Naparstek and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Osteoporosis International.

In The Last Decade

Dana Rosenberg

6 papers receiving 70 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Rosenberg Israel 3 35 35 27 15 13 6 72
Li-Jun Tan China 4 65 1.9× 17 0.5× 55 2.0× 7 0.5× 11 0.8× 4 108
Nadia Arab France 3 76 2.2× 26 0.7× 22 0.8× 8 0.5× 30 2.3× 5 108
Melissa M. Formosa Malta 7 31 0.9× 15 0.4× 28 1.0× 6 0.4× 5 0.4× 12 86
Shaimaa El‐Ashwah Egypt 4 10 0.3× 22 0.6× 4 0.1× 6 0.4× 19 1.5× 31 55
Massimiliano Limonta Italy 3 18 0.5× 17 0.5× 19 0.7× 13 0.9× 10 0.8× 6 83
Alfred Leipold Germany 4 15 0.4× 19 0.5× 6 0.2× 10 0.7× 5 0.4× 9 48
J.-Th. Fischer Germany 5 52 1.5× 28 0.8× 6 0.2× 7 0.5× 14 1.1× 9 101
Stéphanie Kilens France 3 28 0.8× 21 0.6× 4 0.1× 20 1.3× 74 5.7× 4 119
Sæmundur Rögnvaldsson Iceland 5 23 0.7× 19 0.5× 2 0.1× 7 0.5× 8 0.6× 17 61
Damir Gugić Croatia 3 16 0.5× 20 0.6× 4 0.1× 4 0.3× 12 0.9× 13 48

Countries citing papers authored by Dana Rosenberg

Since Specialization
Citations

This map shows the geographic impact of Dana Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Rosenberg more than expected).

Fields of papers citing papers by Dana Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Rosenberg. The network helps show where Dana Rosenberg may publish in the future.

Co-authorship network of co-authors of Dana Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Rosenberg. A scholar is included among the top collaborators of Dana Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Rosenberg. Dana Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Rosenberg, Dana, Tomer Avni, Gloria Tsvetov, Anat Gafter‐Gvili, & Talia Diker‐Cohen. (2020). Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials. Osteoporosis International. 32(3). 413–424. 6 indexed citations
2.
Diker‐Cohen, Talia, Dana Rosenberg, Tomer Avni, et al.. (2020). Risk for Infections During Treatment With Denosumab for Osteoporosis: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 105(5). 1641–1658. 53 indexed citations
3.
Diker‐Cohen, Talia, Dana Rosenberg, Tomer Avni, et al.. (2020). Response to Letter to the Editor: “Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis”. The Journal of Clinical Endocrinology & Metabolism. 105(8). e3038–e3039. 1 indexed citations
4.
Joffe, Erel, Dana Rosenberg, Uri Rozovski, et al.. (2017). Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma. Bone Marrow Transplantation. 53(1). 29–33. 9 indexed citations
5.
Rosenberg, Dana, Erel Joffe, Uri Rozovski, et al.. (2015). Comparison of the Low Toxicity Tecam Conditioning Regimen to BEAM in Patients with Lymphoma Requiring Autologous Stem Cell Transplantation. Blood. 126(23). 3188–3188. 1 indexed citations
6.
Rosenberg, Dana, et al.. (1972). A RARE CONGENITAL MALFORMATION: NON‐UNION OF THE TESTICLE WITH THE EPIDIDYMIS AND THE SPERMATIC DUCT. British Journal of Urology. 44(4). 499–502. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026